| Functional changes of the basal ganglia circuitry in Parkinson's disease F Blandini, G Nappi, C Tassorelli, E Martignoni Progress in neurobiology 62 (1), 63-88, 2000 | 798 | 2000 |
| Animal models of Parkinson’s disease F Blandini, MT Armentero The FEBS journal 279 (7), 1156-1166, 2012 | 490 | 2012 |
| Glutamate and Parkinson’s disease F Blandini, RHP Porter, JT Greenamyre Molecular neurobiology 12, 73-94, 1996 | 416 | 1996 |
| The 6-hydroxydopamine model: news from the past F Blandini, MT Armentero, E Martignoni Parkinsonism & related disorders 14, S124-S129, 2008 | 376 | 2008 |
| Parkinson’s disease in women and men: what’s the difference? S Cerri, L Mus, F Blandini Journal of Parkinson's disease 9 (3), 501-515, 2019 | 302 | 2019 |
| Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues … F Blandini, G Levandis, E Bazzini, G Nappi, MT Armentero European Journal of Neuroscience 25 (2), 397-405, 2007 | 203 | 2007 |
| A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease G Ambrosi, S Cerri, F Blandini Journal of neural transmission 121, 849-859, 2014 | 196 | 2014 |
| Naproxen sodium in menstrual migraine prophylaxis: A double‐blind placebo controlled study G Sances, E Martignoni, L Fioroni, F Blandini, F Facchinetti, G Nappi Headache: The Journal of Head and Face Pain 30 (11), 705-709, 1990 | 179 | 1990 |
| Plasma Homocysteine and l-DOPA Metabolism in Patients with Parkinson Disease F Blandini, R Fancellu, E Martignoni, A Mangiagalli, C Pacchetti, ... Clinical Chemistry 47 (6), 1102-1104, 2001 | 175 | 2001 |
| Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat F Blandini, L Cova, MT Armentero, E Zennaro, G Levandis, P Bossolasco, ... Cell transplantation 19 (2), 203-218, 2010 | 172 | 2010 |
| Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naive and drug-treated patients N Kustrimovic, C Comi, L Magistrelli, E Rasini, M Legnaro, R Bombelli, ... Journal of neuroinflammation 15 (1), 1-17, 2018 | 167 | 2018 |
| Neural and immune mechanisms in the pathogenesis of Parkinson’s disease F Blandini Journal of Neuroimmune Pharmacology 8, 189-201, 2013 | 166 | 2013 |
| Cognitive and affective status in mild hypothyroidism and interactions with l‐thyroxine treatment G Bono, R Fancellu, F Blandini, G Santoro, M Mauri Acta Neurologica Scandinavica 110 (1), 59-66, 2004 | 164 | 2004 |
| Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease L Cova, MT Armentero, E Zennaro, C Calzarossa, P Bossolasco, G Busca, ... Brain research 1311, 12-27, 2010 | 156 | 2010 |
| Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease F Blandini, MT Armentero, R Fancellu, E Blaugrund, G Nappi Experimental neurology 187 (2), 455-459, 2004 | 154 | 2004 |
| Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease G Levandis, E Bazzini, MT Armentero, G Nappi, F Blandini Neurobiology of disease 29 (1), 161-168, 2008 | 123 | 2008 |
| SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration P Milani, G Ambrosi, O Gammoh, F Blandini, C Cereda Oxidative medicine and cellular longevity 2013, 2013 | 122 | 2013 |
| Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease F Blandini, E Sinforiani, C Pacchetti, A Samuele, E Bazzini, R Zangaglia, ... Neurology 66 (4), 529-534, 2006 | 119 | 2006 |
| Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a … MT Armentero, R Fancellu, G Nappi, P Bramanti, F Blandini Neurobiology of disease 22 (1), 1-9, 2006 | 106 | 2006 |
| Inefficient DNA repair is an aging-related modifier of Parkinson’s disease S Sepe, C Milanese, S Gabriels, KWJ Derks, C Payan-Gomez, ... Cell reports 15 (9), 1866-1875, 2016 | 100 | 2016 |
